| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AZD6244 | CCLE | pan-cancer | AAC | -0.15 | 0.0005 |
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | -0.13 | 0.002 |
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | -0.15 | 0.004 |
| mRNA | TAE684 | CCLE | pan-cancer | AAC | -0.13 | 0.004 |
| mRNA | AEW541 | CCLE | pan-cancer | AAC | -0.11 | 0.02 |
| mRNA | RAF265 | CCLE | pan-cancer | AAC | -0.11 | 0.03 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | -0.096 | 0.04 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | 0.1 | 0.07 |
| mRNA | L-685458 | CCLE | pan-cancer | AAC | -0.079 | 0.09 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | -0.08 | 0.1 |